Clinical Trial Update: 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II [Phase 1, Phase 2]

View source ↗

Summary

This Phase I/II clinical trial evaluated Interleukin-7 for T-cell recovery after haploidentical and cord blood stem cell transplantation and has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm

Drugs mentioned

• Interleukin-7 (interleukin-7)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-01